https://www.selleckchem.com/pr....oducts/bip-inducer-x
1% (IQR 0.5-2.3%) for those not at glycemic target. Mean age was 56.5 years and 52.6% were male. At baseline, 28.3% of patients had established cardiovascular disease/chronic kidney disease, and of those 63.8% had HbA1c 8%. African American patients had lower odds of attaining HbA1c 8% when compared with white patients [OR 0.69], while older patients had marginally higher odds [OR 1.01]. Approximately 3 out of 5 patients on metformin and SGLT2i dual therapy achieved HbA1c 8%, with African Americans having a lower l
Curtir
Comentario
Compartilhar
